Company: NDRA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001654954-25-003612
Chunk: 71

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 71
---
 to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. 

We determined that there are no critical audit matters.

/s/ RBSM LLP

We have served as the Company’s auditor since 2015.

RBSM LLP

7915 FM 1960 West, Ste. 220

Houston, Texas 77070

 F-1 

ENDRA Life Sciences Inc.

Consolidated Balance Sheets

  December 31,  December 31, Assets 2024  2023 Current Assets      Cash $3,229,480  $2,833,907 Prepaid expenses  204,185   198,905 Total Current Assets  3,433,665   3,032,812 Non-Current Assets        Inventory  -   2,622,865 Fixed assets, net  69,281   111,782 Right of use assets  578,013   354,091 Prepaid expenses, long term  365,417   626,610 Other assets  5,986   5,986 Total Assets $4,452,362  $6,754,146          Liabilities and Stockholders’ Equity        Current Liabilities        Accounts payable and accrued liabilities $508,293  $700,754 Le